Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
BMJ Open Respiratory Research
|
March 20, 2020
Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015
Jason LeBlanc, May ElSherif, Lingyun Ye, et al.
Vaccine
|
July 27, 2019
Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN)
Jason J LeBlanc, May ElSherif, Lingyun Ye, et al.
Vaccine
|
May 31, 2017
Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study
Jason J LeBlanc, May ElSherif, Lingyun Ye, et al.
Vaccine
|
March 22, 2022
Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay
Jason J LeBlanc, May ElSherif, Lingyun Ye, et al.
Vaccine
|
September 11, 2023
Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)
Henrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
Open Forum Infectious Diseases
|
February 19, 2025
Oseltamivir Reduces 30-Day Mortality in Older Adults With Influenza: A Pooled Analysis From the 2012-2019 Serious Outcomes Surveillance Network of the Canadian Immunization Research Network
Henrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
The Journal of Infectious Diseases
|
September 22, 2017
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People
Melissa K Andrew, Vivek Shinde, Lingyun Ye, et al.
BMC Infectious Diseases
|
December 30, 2017
Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada
Melissa K Andrew, Vivek Shinde, Todd Hatchette, et al.
Open Forum Infectious Diseases
|
July 13, 2023
Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness
May ElSherif, Melissa K Andrew, Lingyun Ye, et al.
Influenza and Other Respiratory Viruses
|
November 11, 2017
Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research Network
Carita Ng, Lingyun Ye, Stephen G Noorduyn, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
BMJ Open Respiratory Research
|
March 20, 2020
Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015
Jason LeBlanc, May ElSherif, Lingyun Ye, et al.
Vaccine
|
July 27, 2019
Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN)
Jason J LeBlanc, May ElSherif, Lingyun Ye, et al.
Vaccine
|
May 31, 2017
Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study
Jason J LeBlanc, May ElSherif, Lingyun Ye, et al.
Vaccine
|
March 22, 2022
Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay
Jason J LeBlanc, May ElSherif, Lingyun Ye, et al.
Vaccine
|
September 11, 2023
Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)
Henrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
Open Forum Infectious Diseases
|
February 19, 2025
Oseltamivir Reduces 30-Day Mortality in Older Adults With Influenza: A Pooled Analysis From the 2012-2019 Serious Outcomes Surveillance Network of the Canadian Immunization Research Network
Henrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
The Journal of Infectious Diseases
|
September 22, 2017
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People
Melissa K Andrew, Vivek Shinde, Lingyun Ye, et al.
BMC Infectious Diseases
|
December 30, 2017
Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada
Melissa K Andrew, Vivek Shinde, Todd Hatchette, et al.
Open Forum Infectious Diseases
|
July 13, 2023
Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness
May ElSherif, Melissa K Andrew, Lingyun Ye, et al.
Influenza and Other Respiratory Viruses
|
November 11, 2017
Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research Network
Carita Ng, Lingyun Ye, Stephen G Noorduyn, et al.
Page
of 6